Vol. 102, No. 1,1981 September
BIOCHEMICAL
AND
BIOPHYSICAL
RESEARCH
COMMUNICATIONS Pages 507-512
16, 1981
ANAEROBIC DEHALOGENATION OF HALOTHANE BY RECONSTITUTED LIVER MICROSOMAL CYTOCHROME P-450 Kohyu Fujii:
Nobuo Miki,
Toshihiro
ENZYME SYSTEM'
Sugiyama,
Michio Miyake3
and Yoshihiro Department
* ?;
Mario':
Toshio
Yamano
J-:t
National Cardiovascular Center Research Institute, :k Fujishiro-dai, Suita, 565, Department of Anesthesiology, Medical School of ** Hiroshima University, Minami-ku, Hiroshima, 734, Department of Biochemistry, Medical School of Osaka University, Kita-ku, Osaka, 530, Japan Received
of Biochemistry,
July
27,198l SUMMARY
Cytochrome P-450 from liver microsomes of phenobarbital-treated rabbits catalyzed anaerobic dehalogenation of halothane (2-bromo-2-chloro-l,l,ltrifluoroethane) when combined with NADPH and NADPH-cytochrome P-450 reductase. Cytochromes P-45031 and P-448 from liver microsomes of untreated rabbits were less active. Triton X-100 accelerated the reaction. Unlike anaerobic dehalogenation of halothane in microsomes, the major product was 2-chloro-l,l,l-trifluoroethane and 2-chloro-l,l-difluoroethylene was negligible. These products were not detected under aerobic conditions, and dehalogenation activity was inhibited by carbon monoxide, phenyl isocyanide and metyrapone.
INTRODUCTION Halothane This Volatile rabbits
is
compound
an anesthetic, is
metabolites, (2).
metabolized
which
is
in vivo -__
now widely and excreted
CF3CH2C1 and CF2CHC1, are
With
respect
to these
demonstrated
that
aerobic
dehalogenation
CF3COOH (3),
while
anaerobic
reaction
metabolites,
used in clinical in urine also recent
of halothane produces
anesthesia.
as CF3COOH (1).
expired studies
from
anesthetized
have
in microsomes
produces
CF3CH2C1 and CF2CHC1 (4).
1. This study was supported in part by Grant-in-aid for Encouragement of Young Scientists No. 56770670 and Grant-in-aid for Science Research Grant No. 448299 from the Ministry of Education, Science and Culture of Japan. 2. On leave from Department of Anesthesiology, Medical School of Hiroshima University, Minami-ku, Hiroshima 734, Japan. 3. To whom all correspondence should be addressed. 0006-291X/81/170507-06$01.00/0 507
Copsvrighl 1,; 1981 by Academic Press, Inc. .A II rights of reproduction in any form reserrled.
BIOCHEMICAL
Vol. 102, No. 1,1981
Moreover,
these
pretreatment that
reactions
of animals
halothane
is
AND
BIOPHYSICAL
inhibited
by carbon
monoxide
phenobarbital
(3,
These
observations
function
oxidase
are with
metabolized
by microsomal
metabolites
are
produced
depending
CF2CHCl are
not
detected
under
been presented halothane it
is
on dehalogenation
to NADPH-reduced
suggested
that
of reduced
cytochrome
microsomal
proteins
have been reported. dehalogenation CF3CH2C1 is
(5).
the major
species Covalent
The present is
product
catalyzed
MATERIALS
and enhanced
Evidence
Anaerobic
strongly by cytochrome
as the reconstituted
CF CH Cl and 3 2
of
carbene
and complex
to liver
from halothane
indicate P-450
and
has also
of halothane
of fluoride
indicate
spectrum,
trifluoroethyl
by
system
addition
a difference
binding
release
experiments
as far
is
COMMUNICATIONS
In fact,
(4).
exhibited
and anaerobic
of halothane
tension.
of halothane.
the spectral
(6)
mixed
conditions
microsomes
P-450
4).
upon oxygen
aerobic
RESEARCH
(7)
that
anaerobic
(P-450)
and
system
is concerned.
AND METHODS
NADPH (Oriental Yeast Co.), Triton X-100 (Rohm and Haas Co.), metyrapone (a generous gift from Ciba Geigy, Japan) and halothane (Hohechist, Japan) were used, respectively. Phenyl isocyanide was prepared by the method of Schmidt and Stern (8). All other reagents were of the highest grade commercially available. Rabbit liver microsomes were prepared by the method of Miki et al. (9). Intra muscular injection of phenobarbital was made on rabbits (40 mg per kg) at intervals of 24 hrs for 5 days, and then the rabbits were fasted for 24 hrs. Cytochrome P-450 from phenobarbital-treated rabbit liver microsomes (P-450PB) was purified by the method for purification of cytochromes P-450Bl and P-448 (9, 10) with a slight modification. The Step 1 preparation in 5 mM potassium phosphate, pH 7.4, containing 0.5% Triton X-100 (w/v), 20% glycerol (v/v> and 1 mM EDTA (5 &I PTGE-buffer) was chromatographed on a CM-Sepharose CL-6B column. The eluate with 20 mM PTGEbuffer was passed through a cytochrome b5-coupled Sepharose 6B column and the flowthrough fractions were collected. The purified preparation was homogeneous on SDS-gel electrophoresis and the properties were identical to those of P-450 prepared by Imai and Sato (11). Cytochromes P-450Bl and P-448 from untreated rabbit liver microsomes (P-450Bl and P-448) were purified by the method of Miki et al. (9, 10). NADPH-P-450 reductase was purified by the method of Yasukochi and Masters (12) with a slight modification. The concentration of P-450 was determined by the method of Omura and Sato (13). NADPH-P-450 reductase activity was assayed by measuring NADPH-cytochrome c reductase activity in 0.3 M potassium phosphate buffer, pH 7.7, containing 0.1 mM EDTA and at 30°C (12). For measurement of anaerobic dehalogenation activity, the reaction mixture contained 0.85-1.1 nmole of P-450, 0.3 unit of NADPH-P-450 reductase, 0.25 pmole of NADPH, 28.5 pmoles of halothane, 100 rmoles of potassium phosphate buffer, pH 7.4, and 0.03% Triton X-100 (w/v) in the total volume of 0.5 ml. A 5 ml test tube containing the reaction mixture was filled with nitrogen gas and sealed by a double cap. The reaction was initiated by injection of NADPH into the test tube, and the reaction was
508
BIOCHEMICAL
Vol. 102, No. 1,198l
Fig.
1. Gas chromatogram the reconstituted metabolite was conditions are
of the system measured described
AND
BIOPHYSICAL
RESEARCH
COMMUNICATIONS
metabolite. Anaerobic reaction was made by containing 2.6 nmoles of P-448. The at 40°C using DOP column. Other experimental in MATERIALS AND METHODS.
carried out at 37'C. After the reaction, an aliquot of the gas phase taken by a microsyringe and analyzed by a Shimadzu gas chromatograph, GC-4A. Determination of CF3CH2C1 and CFzCHCl was made using authentic materials.
was
model
RESULTS Identification performed
of metabolites: by the reconstituted
chromatography. were
observed
Under (Fig.
Anaerobic
and metabolites
system,
the chromatographic 11, one of which
dehalogenation
conditions
was identified
509
of halothane were employed,
assayed only
was by gas two peaks
as CF3CH2C1 and the
other
Vol. 102, No. 1,198l
BIOCHEMICAL
Table
components specificity
(A)
I.
Obligatory and the
Obligatory
AND
of
BIOPHYSICAL
RESEARCH COMMUNICATIONS
for the anaerobic the activity for (B)
components a)
dehalogenation P-450 isozymes
Specificity
for
activity (B).
P-450
(A)
isozymes a)
Components
Activity
Complete system b) - P-450PB
5.0 (100%)
P-450PB
5.0
(100%)
0.4
P-450Bl
4.0
( 80%)
P-448
2.8
( 56%)
-NADPH-P-450 reductase
(
P-450
8%)
undetectable
- NADPH
Activity
undetectable
- Triton
X-100
2.4
( 48%)
a) The activity is expressed as nmoles of CF3CH2Cl formed / nmole of P-450 per 30 min, and the concentration of each P-450 isozyme was 2.2 nmoles per ml. The was used. b) P-450PB was
as unreacted
reconstituted used
in
this
halothane.
Even when P-448
system
as described
reconstituted
in
MATERIALS
AND METHODS
system.
The peak of CF2CHCl was negligible
was replaced
CF3CH2C1 and halothane
by either
were
P-450PB
observed,
but
(arrow
or P-450B1,
in Fig.
the peaks
the peak of CF2,CHC1 could
1).
of
not be
detected. Obligatory
components
Table
I,
NADPH
was
NADPH-P-450
activity
required
fashion
as
and saturated by either
P-448
of inhibitors
and metyrapone the
test
that
of the control
less
than
reaction
that under
inhibited
0.3 unit
did
not
per
and
the maximum
X-100.
The activity
and increased
in a linear
at least
nmole
in
up to 4 nmoles
per
of NADPH-P-450
of P-450PB. with
P-448
When P-450PB and P-450Bl
respectively.
the reaction. monoxide,
The extent anaerobic
produce
As shown
the reaction
shown that
As shown in Table
by carbon
with
for
upon the concentration
P-450PB,
activity.
observed air
of P-450PB
on the reaction:
tube was replaced
was also
or P-450B 1, the activity
with
strongly
essential
of P-450PB
dependent at around
of halothane:
of 0.03% Triton
concentration
was also
were
It
donor.
in the presence
was 56% and 80% of that Effect
and P-450
electron
increasing
The activity
was replaced
dehalogenation
upon the concentration
with
reductase
anaerobic
reductase
was attained
was dependent
ml.
for
Vhen nitrogen the activity
of inhibition reaction
II,
in microsomes
isocyanide
gas phase decreased
by carbon
any CF3CH2C1 or CF2CHCl.
510
phenyl
in to 24%
monoxide (4).
The
was
Vol. 102, No. 1,198l
Table
II.
BIOCHEMICAL
Effect
of
AND
inhibitors
BIOPHYSICAL
on the
Conditions
anaerobic
Residual activity
Complete
b)
system
+ Ethanol
(0.02%)
+ Phenyl
isocyanide
(20 TM)') C)
+ Metyrapone
(10
ti)
under
carbon
monoxide
under
aird)
RESEARCH COMMUNICATIONS
d)
dehalogenation Per
a)
activity.
cent residual activity (X)
3.8
100
4.1
108
0.3
8
0.3
8
0.9
24
undetectable
0
a)
The activity is expressed as nmoles of CF3CH2Cl formed / nmole of P-450 per 30 min. b) The concentration of each component is described in MATERIALS AND METHODS, and P-450PB (1.7 nmole/ml) was used in this reconstituted system. c) Phenyl isocyanide and metyrapone were dissolved in ethanol, and the concentration of ethanol in the reaction mixture was 0.02%. d) Nitrogen gas in the sealed test tube was replaced by either carbon monoxide or air. Values in parentheses represent the final concentration of the inhibitors and ethanol.
DISCUSSION The
present
of
halothane
In
fact,
investigation is the
containing that
catalyzed
maximum P-450PB
anaerobic of
indicating is
the
is
associated
to
loss
of
trifluoroethyl
with
the
halothane
with
catalyzed
by
remain
result
of
halothane
the
the
mode
of carbene
present molecule
results, along
or is
when is
be is
of
binding
of
complex since
CF'CHCl
P-450 of
to reduced
elimination the
also
showed
complex
511
As
the
of formation
P-450PB,
reaction
CF2CHC1
is
microsomal
microsomal P-450
activity,
the
exist,
chloride has
but mechanism,
not
produced
component or
it
might
membrane. does
by
reconstituted
for
to
observation
enhanced
the
why
might
the is
specific
other
system
with
However,
reason
system.
reconstituted
(4).
Some
unknown.
formation
with
The
dehalogenation oxidase
microsomes
isozymes.
solved.
function
the
necessarily
P-450
anaerobic
consistent in
P-450Bl
not
these
system with
attained
phenobarbital
to
that mixed
This
P-448
reaction
reconstituted
of
used.
the
problems
by
was
either
indicated
P-450-dependent
activity
rabbits
that
several
by
was
containing
halothane
strongly
dehalogenation
pretreatment system
has
be
due
The
formation
to
reconcile
not
seem
and
bromide
been
which
suggested
from
the (5).
Vol. 102, No. 1,1981
In connection
with
were
after
produced
further.
assumed
problem,
even if
Two possible
elucidation
(14).
of these
the
radical
30 min,
problems
it
exists,
mechanisms
it
is
or one-electron
await
might
in which
However,
must
COMMUNICATIONS
and the reaction
reaction
species
RESEARCH
of CF3CH2Cl per nmole
of halothane,
a two-electron
Moreover,
5 nmoles
the complex,
as an intermediate
halothane.
BIOPHYSICAL
for
dehalogenation
by either
AND
the reaction
intermediate.
anaerobic
formed
this
Therefore,
containing for
BIOCHEMICAL
have been proposed
whether
metabolic
continued
be a chloride
a radical
unknown
of P-450
species
CF3CH2Cl is
reduction
has not
been
identified
further
investigations.
was
of yet.
The
REFERENCES 1. Cohen, E. N., Trudell, J. R., Edmunds, H. N., and Watson, E. (1975) Anesthesiology 43, 392-401. 2. Mukai, S., Morio, M., and Fujii, K. (1977) Anesthesiology 47, 248-251. 3. Karashima, D., Hirokata, Y., Shigematsu, A., and Furukawa, T. (1977) J. Pharmacol. Exptl. Ther. 203, 409-416. 4. Fujii, K., Chikasue, F., and Morio, M. (1980) Proc. 1st Japanese Symp. on Biotransformation and Hepatotoxicity of Anesthetics (Morio, M. ed.) Suppl. 16, pp. 11-14, Hiroshima J. Anesthesia. 5. Nastainczyk, W., and Ullrich, V. (1978) Biochem. Pharmacol. 27, 387-392. 6. Uehleke, H., Hellmer, K. H., and Tabarelli-Poplawski, S. (1973) Naunyn-Schmiedeberg's Arch. Pharmacol. 279, 39-52. 7. Van Dyke, R. A., and Gandolfi, A. J. (1976) Drug Metab. Dispos. 4, 40-44. 8. Schmidt, P., and Stern, D. (1929) Beilsteins Handbuch der Organischen Chemie Vol. XII, p. 191, Julius Springer, Berline. 9. Miki, N., Sugiyama, T., and Yamano, T. (1980) .I. Biochem. 88, 307-316. 10. Miki, N., Sugiyama, T., and Yamano, T. (1980) Microsomes, Drug Oxidations, and Chemical Carcinogenesis (Coon, M. J., Conney, A. H., Estabrook, R. W., Gelboin, H. V., Gillette, J. R., and O'Brien, P. J. eds.) Vol. I, pp. 27-36, Academic Press, New York, 11. Imai, Y., and Sato, R. (1974) Biochem. Biophys. Res. Commun. 60, 8-14. 12. Yasukochi, Y., and Masters, B. S. S. (1976) J. Biol. Chem. 251, 5337-5344. 13. Omura, T., and Sato, R. (1964) J. Biol. Chem. 239, 2379-2385. 14. Goldblum, A., and Loew, G. H. (1980) Chem. Biol. Interactions 32, 83-99.
512